source
- Biogen's litifilimab shows clear or almost clear skin in cutaneous lupus after one yearBiogen reported that its experimental antibody litifilimab produced clear or almost clear skin in patients with cutaneous lupus erythematosus after one year of treatment in a mid‑stage study. The r…
- Vaxcyte’s pneumococcal vaccine meets primary goals in Phase 3 trial, challenging Pfizer and MerckVaxcyte announced that its experimental pneumococcal vaccine, VAX-31, achieved the primary endpoints in a pivotal Phase 3 study. The data, presented in a company release, show the shot met its pred…